The Future of Myasthenia Gravis: Exploring the Onset, Progression and Implications of Disease
Myasthenia gravis (MG) is an autoimmune disease whose name means "grave muscular weakness". MG is a rare disease affecting only 200-400 persons per million and the characteristic symptoms include muscle weakness, particularly in highly active voluntary muscles. MG affects the neuromuscular...
Main Author: | Paluszcyk, Chana Renee |
---|---|
Other Authors: | Wilson, Jean |
Language: | en_US |
Published: |
The University of Arizona.
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/613371 http://arizona.openrepository.com/arizona/handle/10150/613371 |
Similar Items
-
Treatment of Autoimmune Myasthenia Gravis
by: J Gordon Millichap
Published: (2004-02-01) -
Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications
by: Kaori Noridomi, et al.
Published: (2017-04-01) -
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
by: Konstantinos Lazaridis, et al.
Published: (2020-02-01) -
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
by: Konstantinos Lazaridis, et al.
Published: (2020-11-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01)